BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6599938)

  • 1. Fibrin-mediated vascular injury: demonstration of vascular endothelial cell retraction in response to soluble fibrin-associated factors.
    Rowland FN; Donovan MJ; Picciano PT; Kreutzer DL
    J Exp Pathol; 1984; 1(3):217-40. PubMed ID: 6599938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction.
    Rowland FN; Donovan MJ; Picciano PT; Wilner GD; Kreutzer DL
    Am J Pathol; 1984 Dec; 117(3):418-28. PubMed ID: 6507588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin activation of vascular endothelial cells. Induction of IL-8 expression.
    Qi J; Kreutzer DL
    J Immunol; 1995 Jul; 155(2):867-76. PubMed ID: 7608564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific fibrinogen and thrombin concentrations promote neuronal rather than glial growth when primary neural cells are seeded within plasma-derived fibrin gels.
    Mooney R; Tawil B; Mahoney M
    Tissue Eng Part A; 2010 May; 16(5):1607-19. PubMed ID: 20028220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.
    Bootle-Wilbraham CA; Tazzyman S; Marshall JM; Lewis CE
    Cancer Res; 2000 Sep; 60(17):4719-24. PubMed ID: 10987275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin induction of ICAM-1 expression in human vascular endothelial cells.
    Qi J; Kreutzer DL; Piela-Smith TH
    J Immunol; 1997 Feb; 158(4):1880-6. PubMed ID: 9029129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration.
    Nehls V; Herrmann R
    Microvasc Res; 1996 May; 51(3):347-64. PubMed ID: 8992233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fibrin-neutrophil interactions in lung vascular injury.
    Malik AB
    Prog Clin Biol Res; 1987; 236A():33-42. PubMed ID: 3615438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.
    Watanabe K; Tanaka K
    Atherosclerosis; 1983 Jul; 48(1):57-70. PubMed ID: 6882509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.
    de Boer HC; Verseyden C; Ulfman LH; Zwaginga JJ; Bot I; Biessen EA; Rabelink TJ; van Zonneveld AJ
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1653-9. PubMed ID: 16627804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
    Akakura N; Hoogland C; Takada YK; Saegusa J; Ye X; Liu FT; Cheung AT; Takada Y
    Cancer Res; 2006 Oct; 66(19):9691-7. PubMed ID: 17018627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
    Guo F; Liu J; Wang C; Liu N; Lu P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells.
    Lorenzet R; Sobel JH; Bini A; Witte LD
    Thromb Haemost; 1992 Sep; 68(3):357-63. PubMed ID: 1440505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.